Home » News » CROs/Service Providers » BioClinica Reports Flat Earnings, Adjusts 2010 EPS Guidance

BioClinica Reports Flat Earnings, Adjusts 2010 EPS Guidance

Wednesday, May 5, 2010

BioClinica’s first quarter 2010 earnings were flat compared with the same period 2009, with service revenues of $14.7 million. First quarter revenues last year were $14.5 million. Net income was $711,000, or $0.05 per diluted share, compared with $786,000, or $0.05 per diluted share for Q1 2009.

The company, which acquired clinical trial management software company TranSenda a month ago, reiterated its full-year 2010 service revenue forecast of $61 million to $65 million, but revised its earnings per share estimate to be in the range $0.23 to $0.27 per share (down from $0.25 to $0.29) to account for the financial impact of the TranSenda transaction.

 

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!